GÜLLE, S. Et Al. 2022. Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort. ARTHRITIS & RHEUMATOLOGY , 843-845.

GÜLLE, S., KARAKAŞ, A., CAN, G., Senel, S., ÇAPAR, S., DALKILIÇ, H. E., ... AKAR, S.(2022). Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort. ARTHRITIS & RHEUMATOLOGY , 843-845.

GÜLLE, SEMİH Et Al. "Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort," ARTHRITIS & RHEUMATOLOGY , 843-845, 2022

GÜLLE, SEMİH Et Al. "Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort." ARTHRITIS & RHEUMATOLOGY , pp.843-845, 2022

GÜLLE, S. Et Al. (2022) . "Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort." ARTHRITIS & RHEUMATOLOGY , pp.843-845.

@article{article, author={SEMİH GÜLLE Et Al. }, title={Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2022, pages={843-845} }